Patent Assignment
Reel/Frame 036477/0455
Assignment of Assignor's Interest
Recorded: 2015-09-02
Pages: 4
Assignor
COPE, FREDERICK O.
Executed: 2015-08-30
Assignee
NAVIDEA BIOPHARMACEUTICALS, INC.
11-5 ADDRESS 5600 BLAZER PARKWAY, SUITE 200, DUBLIN, OHIO, 43017
Covered Properties
(3)
Compounds and Compositions for Targeting Macrophages and Other Mannose-Binding C-Type Lectin Receptor High Expressing Cells and Methods of Treating and Diagnosis Using Same
Compounds and Compositions for Targeting Macrophages and Other CD206 High Expressing Cells and Methods of Treating and Diagnosis Using Same
Application:
62/106,194 →
Compounds and Compositions for Targeting Macrophages and Other CD206 High Expressing Cells and Methods of Treating and Diagnosis Using Same
Application:
62/187,064 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
May 15, 2015
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 035653/0441 →
Release of Security Interest
Mar 9, 2017
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 041518/0749 →
Assignment of Assignor's Interest
Mar 20, 2017
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: CARDINAL HEALTH 414, LLC
Reel/Frame 041645/0574 →
Assignment of Assignor's Interest
Sep 1, 2020
From: THE OHIO STATE UNIVERSITY
To: OHIO STATE INNOVATION FOUNDATION
Reel/Frame 053661/0639 →